Home › NDC Lookup › RxCUI directory › RxCUI 309680

Dexamethasone 1 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Ophthalmic Suspensio... — RxCUI 309680

RxNorm drug concept · Semantic clinical drug
RxCUI 309680 Semantic clinical drug · SCD ● Current RxNorm concept 10 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI309680
Official nameDexamethasone 1 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Ophthalmic Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdexamethasone 0.1 % / neomycin 0.35 % / polymyxin B 10,000 UNT per ML Ophthalmic Suspension; neomycin sulfate 3.5 MG/ML / polymyxin B sulfate 10,000 UNT/mL / dexAMETHasone 0.1 % Ophthalmic Suspension
FDA products mapped10
Package NDCs mapped10
Reported Medicaid activity (SDUD)203,509 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dexamethasone Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • You're right — it does treat a wide range of conditions, and that can feel a bit overwhelming. Basically, dexamethasone is a powerful anti-inflammatory medication that works across...
  • What is dexamethasone injection actually used for? It seems like it treats a lot of different things.
  • Yes, that's an important one. Dexamethasone does suppress the immune system, which means your body has a harder time fighting off infections while you're on it. It can also make ex...
  • Will this injection affect my immune system? Should I avoid sick people?
📖 Read our full Dexamethasone Injection guide →

🕸️ Concept Web — How Dexamethasone 1 MG/ML / neomycin 3.5 MG/ML / pol... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dexamethasone 1 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Ophthalmic Suspension RxCUI 309680

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Dexamethasone 3264
    • Neomycin 7299
    • Polymyxin B 8536
    • Dexamethasone / neomycin / polymyxin B 216525
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Maxitrol 134920
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dexamethasone / neomycin / polymyxin B Ophthalmic Suspension 374698
    • Dexamethasone / neomycin / polymyxin B Ophthalmic Product 1154245
    • Dexamethasone / neomycin / polymyxin B Ophthalmic Suspension [Maxitrol] 93250
    • Maxitrol Ophthalmic Product 1182730
    • Ophthalmic Suspension 316964
    • Ophthalmic Product 1151135
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dexamethasone 1 MG/ML SCDC · 317629
  • Neomycin 3.5 MG/ML SCDC · 316332
  • Polymyxin B 10000 UNT/ML SCDC · 316526
  • Dexamethasone / neomycin / polymyxin B Ophthalmic Suspension SCDF · 374698
  • Dexamethasone / neomycin / polymyxin B Ophthalmic Product SCDG · 1154245

Brand-Name Concepts

📦 FDA Products & Package NDCs

10 products · 10 package NDCs
10 package NDCs map to RxCUI 309680 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
24208-0830-60 1 BOTTLE, DROPPER in 1 CARTON (24208-830-60) / 5 mL in 1 BO... Neomycin Polymyxin B Sulfates and Dexamethasone Bausch & Lomb Incorporated 1995-09-13
50090-0570-00 1 BOTTLE, DROPPER in 1 CARTON (50090-0570-0) / 5 mL in 1 BO... Neomycin Polymyxin B Sulfates and Dexamethasone A-S Medication Solutions 2016-06-29
61314-0630-06 5 mL in 1 BOTTLE, PLASTIC (61314-630-06) Neomycin and Polymyxin B Sulfates and Dexamethasone Sandoz Inc. 1996-02-21
63187-0498-05 1 BOTTLE, DROPPER in 1 CARTON (63187-498-05) / 5 mL in 1 BO... Neomycin Polymyxin B Sulfates and Dexamethasone Proficient Rx LP 2015-02-02
68071-3359-05 5 mL in 1 BOX (68071-3359-5) Neomycin and Polymyxin B Sulfates and Dexamethasone NuCare Pharmaceuticals,Inc. 2017-07-21
68071-4375-05 5 mL in 1 BOX (68071-4375-5) Neomycin Polymyxin B Sulfates and Dexamethasone NuCare Pharmaceuticals,Inc. 2018-04-05
68788-9702-05 1 BOTTLE, DROPPER in 1 CARTON (68788-9702-5) / 5 mL in 1 BO... Neomycin Polymyxin B Sulfates and Dexamethasone Preferred Pharmaceuticals, Inc. 2013-03-14
69918-0515-05 5 mL in 1 BOTTLE, PLASTIC (69918-515-05) neomycin sulfate, polymyxin b sulfate and dexamethasone Nordic Pharma, Inc. 2025-03-31
72189-0320-05 5 mL in 1 BOTTLE (72189-320-05) NEOMYCIN POLYMYXIN B SULFATES AND DEXAMETHASONE DirectRx 2022-01-18
82667-0100-05 5 mL in 1 BOTTLE, PLASTIC (82667-100-05) Maxitrol Harrow Eye, LLC 2023-11-01
Observed labelers: NuCare Pharmaceuticals,Inc. (2) · A-S Medication Solutions (1) · Bausch & Lomb Incorporated (1) · DirectRx (1) · Harrow Eye, LLC (1) · Nordic Pharma, Inc. (1) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.